C0087111||Treatment
C0286651||atorvastatin
C0178324||vascular injury
C0011849||diabetic
C0086893||rats
C0087111||treatment
C0360714||statin
C0011849||Diabetes mellitus
C0011849||Diabetes mellitus
C0087111||treatment
C0286651||atorvastatin
C0232337||vascular function
C0011849||diabetic
C0086893||rats
C0286651||Atorvastatin
C0042444||vehicle
C0038432||streptozotocin
C0038432||streptozotocin
C0011849||diabetic
C0086893||rats
C0506947||Aortic segments
C1171362||protein expression
C0387583||cyclooxygenase-2
C0387583||cyclooxygenase-2
C1417769||nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) 1
C1417769||NOX1
C0038836||superoxide anions
C0286651||Atorvastatin
C0087111||treatment
C0392201||glycemia levels
C0011849||diabetic
C0086893||rats
C0031469||phenylephrine
C0286651||atorvastatin
C0087111||treatment
C0014257||endothelium
C0031469||phenylephrine
C0286651||Atorvastatin
C0011849||diabetic
C0086893||rats
C0083536||L-NAME
C0286651||atorvastatin
C0011849||diabetic
C0086893||rats
C0021246||Indomethacin
C1567346||NS398
C1511498||contractile
C0011849||diabetic
C0086893||rats
C0286651||atorvastatin
C0387583||cyclooxygenase-2
C1171362||expression
C0050465||Apocynin
C0031469||phenylephrine
C0011849||diabetic
C0086893||rats
C1417769||NOX1
C0038836||superoxide anions
C0286651||atorvastatin
C0087111||treatment
C0087111||treatment
C0286651||atorvastatin
C0005802||glycemia
C0014257||endothelial
C0003483||aortas
C0011849||diabetic
C0086893||rats
C0033554||constrictor prostanoids
C0387583||cyclooxygenase-2
C0242606||oxidative stress
C0068355||NADPH oxidase
C0028128||nitric oxide